0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Observation |

Intraparenchymal Hemorrhage in a Patient With Osteogenesis Imperfecta and Plasminogen Activator Inhibitor-1 Deficiency FREE

Richard P. Goddeau Jr, DO; Louis R. Caplan, MD; Adel A. Alhazzani, MD
[+] Author Affiliations

Author Affiliations: Department of Neurology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire (Dr Goddeau); and Departments of Neurology (Dr Caplan) and Radiology (Dr Alhazzani), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.


Arch Neurol. 2010;67(2):236-238. doi:10.1001/archneurol.2009.319.
Text Size: A A A
Published online

ABSTRACT

Background  Osteogenesis imperfecta is associated with susceptibility to connective tissue damage, including intracranial but usually extra-axial hemorrhage. Plasminogen activator inhibitor-1 deficiency is a rare fibrinolytic cause of systemic bleeding diathesis.

Objective  To describe a case of a brainstem intraparenchymal hemorrhage associated with connective tissue and coagulation disorders.

Design  Case report.

Setting  Academic medical center.

Patient  A 36-year-old woman with a history of osteogenesis imperfecta presented to the emergency department after an argument, during which she developed left ear pain and right eye esotropia followed by quadriparesis and somnolence. Neuroimaging showed a tegmental mesencephalic hemorrhage.

Main Outcome Measures  Results of computerized tomography, magnetic resonance angiography, and parenchymal imaging; and serum hematologic markers.

Results  No underlying vascular abnormality or mass lesion was found. Among coagulopathic serum markers, only plasminogen activator inhibitor-1 activity level was abnormally low.

Conclusion  Intraparenchymal hemorrhage may occur in the setting of a fibrinolytic inhibitory deficiency and osteogenesis imperfecta.

Figures in this Article

Of the 10% to 15% of strokes that are caused by nontraumatic intraparenchymal (ie, intracranial and intra-axial) hemorrhage, most are spontaneous, presumed to be due to hypertension or amyloid angiopathy, and are classified as primary. In fewer than 25% of cases is an underlying abnormality, such as vascular malformation, tumor, or coagulopathy, found.1 This is a case report of an unusual spontaneous intraparenchymal hemorrhage in a patient with osteogenesis imperfecta and plasminogen activator inhibitor-1 activity deficiency.

REPORT OF A CASE

A 36-year-old woman with a history of osteogenesis imperfecta presented after an argument with her son. She first noted a sudden pain in her left ear associated with a feeling of being light-headed. Then she felt her right eye turning in, found it difficult to speak, and felt that she would pass out. She lost consciousness in the ambulance that took her to the hospital.

When she was first examined in the emergency department, she was comatose and did not awaken to stimuli. Her right eye was deviated down and in, and her eyes remained skewed downward. There was limited upgaze. On left gaze there was torsional nystagmus. The right pupil was 4 mm, the left 4.5 mm; each reacted to light. She moved the left limbs better than the right to noxious stimuli. Noncontrast head computed tomography showed and brain magnetic resonance imaging (Figure) confirmed a left tegmental mesencephalic hemorrhage. Toxicology screen results were negative.

Place holder to copy figure label and caption
Figure.

Imaging in a 36-year-old woman with osteogenesis imperfecta and plasminogen activator inhibitor-1 deficiency. Noncontrast head computed tomography (A) and magnetic resonance imaging fluid-attenuated inversion recovery (B) sequence showing hemorrhage location.

Graphic Jump Location

On the second hospital day, the patient became more alert. After extubation, she noted vertical diplopia and hypesthesia on the left side of her face and right arm. Her sclerae were blue. Her right eye was deviated down and in. Her left eye was also deviated inward. On upgaze, there were convergence movements of both eyes. Computed tomographic angiography and follow-up magnetic resonance angiography, including time-of-flight sequencing, showed no underlying tumor or vascular malformation. No additional areas of hemorrhage were found. Serum coagulation cascade markers, platelet function studies, the von Willebrand factor, and fibrinolytic markers α2-antiplasmin and plasminogen activator inhibitor-1 (PAI-1) antigen levels were normal. However, PAI-1 activity was undetectable.

COMMENT

Osteogenesis imperfecta is a connective tissue disorder with varying clinical presentations, typified by bone fragility, ligamentous laxity, and easy bruising. Rarely, osteogenesis imperfecta is complicated by intracranial bleeding.2 Case reports, most often in pediatric populations, have described epidural, subdural, subarachnoid, and retinal hemorrhages.2,3

Four subtypes, based on particular collagen mutation and phenotype, are described. Classic, type 1 osteogenesis imperfecta is characterized by bluish sclerae and, typically, COL1A1 or COL1A2 gene mutation.4 Collagen mutations in osteogenesis imperfecta lead to platelet dysfunction and vascular wall fragility, which account for easy bruising and hemorrhages due to trivial trauma. The relative scarcity of type 1 collagen in smaller intracerebral vessels5 may account for the predominance of subdural or subarachnoid over intraparenchymal hemorrhages in osteogenesis imperfecta. Nontraumatic spontaneous intraparenchymal hemorrhage in osteogenesis imperfecta has not, to our knowledge, been previously described.

In our patient, the additional finding of PAI-1 activity deficiency likely contributed to her hemorrhage. Plasminogen activator inhibitor-1 is a main inhibitor of tissue-type and urokinase-type plasminogen activators. Elevated plasma PAI-1 levels have been associated with myocardial infarction and venous thrombosis. Deficiencies in PAI-1 have been found in patients with a predilection for easy bruising or bleeding from trivial trauma.6 Plasminogen activator inhibitor-1 deficiency has been characterized either by reduced expression of the protease inhibitor or by decreased activity of normal amounts of PAI-1 (eg, PAI-1 activity deficiency). Structural abnormalities affecting the PAI-1 molecule's binding capacity to plasminogen activator or the presence of PAI-1–binding antibodies have been suggested as reasons for decreased functional activity despite normal measured levels of PAI-1.7

The tegmental mesencephalic hemorrhage was in an unusual location. The patient had no history of hypertension nor was she hypertensive during her hospital admission or afterwards. Vascular imaging excluded a vascular malformation. There had been no trauma. We posit that our patient's collagen disease and fibrinolytic inhibition deficiency, in the setting of situational hypertension, caused the intraparenchymal hemorrhage.

ARTICLE INFORMATION

Correspondence: Richard P. Goddeau Jr, DO, Department of Neurology, Dartmouth Hitchcock Medical Center, 1 Medical Center Dr, Lebanon, NH 03756 (richard.p.goddeau@hitchcock.org).

Accepted for Publication: February 27, 2009.

Author Contributions:Study concept and design: Caplan. Acquisition of data: Goddeau and Caplan. Analysis and interpretation of data: Goddeau, Caplan, and Alhazzani. Drafting of the manuscript: Goddeau. Critical revision of the manuscript for important intellectual content: Goddeau, Caplan, and Alhazzani. Administrative, technical, and material support: Goddeau, Caplan, and Alhazzani. Study supervision: Caplan.

Financial Disclosure: None reported.

REFERENCES

Qureshi  AITuhrim  SBroderick  JPBatjer  HHHondo  HHanley  DF Spontaneous intracerebral hemorrhage. N Engl J Med 2001;344 (19) 1450- 1460
PubMed Link to Article
Sasaki-Adams  DKulkarni  ARutka  JDirks  PTaylor  MDrake  JM Neurosurgical implications of osteogenesis imperfecta in children. J Neurosurg Pediatr 2008;1 (3) 229- 236
PubMed Link to Article
Narváez  JNarvaez  JAMajos  CClavaguera  MTAlegre-Sancho  JJ Subarachnoid haemorrhage secondary to ruptured cerebral aneurysm in a patient with osteogenesis imperfecta. Br J Rheumatol 1996;35 (12) 1332- 1333
PubMed Link to Article
Sillence  DOSenn  ADanks  DM Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 1979;16 (2) 101- 116
PubMed Link to Article
Verkh  ZRussell  MMiller  CA Osteogenesis imperfecta type II: microvascular changes in the CNS. Clin Neuropathol 1995;14 (3) 154- 158
PubMed
Schleef  RRHiggins  DLPillemer  ELevitt  LJ Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor. J Clin Invest 1989;83 (5) 1747- 1752
PubMed Link to Article
Fay  WPParker  ACCondrey  LRShapiro  AD Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene. Blood 1997;90 (1) 204- 208
PubMed

Figures

Place holder to copy figure label and caption
Figure.

Imaging in a 36-year-old woman with osteogenesis imperfecta and plasminogen activator inhibitor-1 deficiency. Noncontrast head computed tomography (A) and magnetic resonance imaging fluid-attenuated inversion recovery (B) sequence showing hemorrhage location.

Graphic Jump Location

Tables

References

Qureshi  AITuhrim  SBroderick  JPBatjer  HHHondo  HHanley  DF Spontaneous intracerebral hemorrhage. N Engl J Med 2001;344 (19) 1450- 1460
PubMed Link to Article
Sasaki-Adams  DKulkarni  ARutka  JDirks  PTaylor  MDrake  JM Neurosurgical implications of osteogenesis imperfecta in children. J Neurosurg Pediatr 2008;1 (3) 229- 236
PubMed Link to Article
Narváez  JNarvaez  JAMajos  CClavaguera  MTAlegre-Sancho  JJ Subarachnoid haemorrhage secondary to ruptured cerebral aneurysm in a patient with osteogenesis imperfecta. Br J Rheumatol 1996;35 (12) 1332- 1333
PubMed Link to Article
Sillence  DOSenn  ADanks  DM Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 1979;16 (2) 101- 116
PubMed Link to Article
Verkh  ZRussell  MMiller  CA Osteogenesis imperfecta type II: microvascular changes in the CNS. Clin Neuropathol 1995;14 (3) 154- 158
PubMed
Schleef  RRHiggins  DLPillemer  ELevitt  LJ Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor. J Clin Invest 1989;83 (5) 1747- 1752
PubMed Link to Article
Fay  WPParker  ACCondrey  LRShapiro  AD Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene. Blood 1997;90 (1) 204- 208
PubMed

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

1,043 Views
4 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
Jobs